Private equity firm Graphite Capital has followed up on its recent investment in the Hawksmoor chain of restaurants by exiting its interest in Willowbrook Healthcare.
An $11 million investment from Index Ventures will be used to develop an anticoagulant drug aimed at preventing heart attacks and strokes without causing bleeding.